Milestone Scientific (NYSE:MLSS) Coverage Initiated at StockNews.com

Research analysts at StockNews.com initiated coverage on shares of Milestone Scientific (NYSE:MLSS) in a research report issued to clients and investors on Friday. The brokerage set a “hold” rating on the stock.

Separately, Benchmark reissued a “speculative buy” rating and issued a $1.25 price target on shares of Milestone Scientific in a report on Wednesday, November 20th.

Milestone Scientific Stock Up 16.0 %

Shares of NYSE:MLSS opened at $0.93 on Friday. Milestone Scientific has a 52 week low of $0.52 and a 52 week high of $1.10. The company has a 50-day moving average price of $0.81 and a 200 day moving average price of $0.86. The company has a market cap of $72.05 million, a P/E ratio of -13.21 and a beta of 1.10.

Insider Transactions at Milestone Scientific

In related news, Director Leonard Osser sold 107,984 shares of Milestone Scientific stock in a transaction on Tuesday, October 22nd. The stock was sold at an average price of $0.93, for a total transaction of $100,425.12. Following the completion of the transaction, the director now directly owns 4,606,882 shares of the company’s stock, valued at approximately $4,284,400.26. The trade was a 2.29 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Insiders have sold a total of 128,193 shares of company stock valued at $116,234 in the last ninety days. 24.75% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Milestone Scientific

Several institutional investors and hedge funds have recently made changes to their positions in the business. Y Intercept Hong Kong Ltd purchased a new position in Milestone Scientific during the third quarter worth $48,000. World Investment Advisors LLC acquired a new position in Milestone Scientific in the 3rd quarter valued at about $91,000. Finally, Geode Capital Management LLC raised its stake in Milestone Scientific by 6.4% in the 3rd quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock valued at $480,000 after purchasing an additional 31,572 shares during the last quarter. 5.79% of the stock is currently owned by hedge funds and other institutional investors.

Milestone Scientific Company Profile

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.